Insights & Discussion
Acupuncture shows promising potential in providing symptom relief for women with adenomyosis and may be considered as an alternative treatment to surgery and pharmacological medicine, based on a systematic review and meta-analysis of randomized controlled trials.
This systematic review examined the effects of acupuncture on relieving adenomyosis symptoms. Eleven randomized controlled trials involving 942 women were included. Acupuncture was found to significantly reduce uterine size and CA125 levels compared to pharmacological medicine alone. It also improved dysmenorrheal symptoms after three months of treatment. Additionally, the incidence of adverse events, especially hot flashes, was lower in the acupuncture group. The study suggests that acupuncture holds promise as an alternative treatment for adenomyosis, but further rigorous trials are required to confirm these findings.
Discover Related Insights
Gui Zhi Fu Ling Wan can lessen the expression of certain proteins, which may be key to its ability to impede abnormal tissue invasion and metastasis in adenomyosis.
2022 Evidence-Based Complementary and Alternative Medicine Analysis of the Mechanism of GuizhiFuling Wan in Treating Adenomyosis Based on Network Pharmacology Combined with Molecular Docking and Experimental Verification Shi Y, Zhang C, Wang X, Wang Z, Zhang Y, Liu Z, et al.
Network Pharmacology Adenomyosis Gui Zhi Fu Ling Wan
Firstly, an approach called network pharmacology was utilized which involved identifying active components of GuizhiFuling Wan (GFW), its drug targets and disease targets through public databases, and finding shared targets. The biological function and pathway of GFW in treating adenomyosis were analyzed. Then, the interaction and strength of binding between key components and targets of GFW were verified by a method known as molecular docking. In the animal part of the study, the impact of GFW on the expression of several proteins in mice with adenomyosis was observed using different staining, protein analysis, and immunohistochemical techniques.
Through collecting and intersecting data, 26 common targets were identified, with the key active compounds being baicalein, sitosterol, and -sitosterol, and the key targets being certain proteins. Enrichment analyses showed that processes such as the positive regulation of vascular endothelial migration and signaling pathways were involved in regulating angiogenesis, invasion, and metastasis in adenomyosis. Furthermore, the molecular docking results suggested that the key active compounds had substantial binding potential with the key proteins.
In vivo analysis suggested that GFW could decrease the serum content and protein expression of certain proteins in mice with adenomyosis. These findings reinforce the hypothesis that reducing the expression of these proteins might be a significant mechanism for GFW in inhibiting the invasion and metastasis of atypical tissues associated with adenomyosis.
Gui Zhi Fu Ling Wan treats adenomyosis by intervening in local estrogen signalling pathways and affecting estrogen resistance via myometrium signalling pathways.
2021 Evidence-Based Complementary and Alternative Medicine Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis Wang H, Zhang J, Zhu Q, Fu X, Li C
Network Pharmacology Adenomyosis Gui Zhi Fu Ling Wan
This study utilized network pharmacology, molecular docking and animal experiments to understand the treatment mechanisms of Guizhi Fuling Wan on adenomyosis. Initially, key indices and target components of the traditional Chinese medicine were identified through various databases, which resulted in isolation of 55 active ingredients and 44 targets specifically related to adenomyosis treatment. These components were then subjected to protein interaction analysis and compound-hub target network constructions. Main active elements and hub targets were subsequently studied with molecular docking tech.
The pathway enrichment analysis showed that the medicinal effects were primarily linked to estrogen signaling, endocrine resistance, and a specific tyrosine kinase signaling pathway. The molecular docking revealed that significant compounds of Guizhi Fuling Wan had a strong binding ability with a couple of cellular receptors. Animal trials indicated that this medicine could reduce abnormal infiltration of specific cells without interrupting normal sexual cycles. These results point towards the importance of the estrogen signaling pathway and cell receptors in the treatment capabilities of Guizhi Fuling Wan.
So far, the first SR on adenomyosis. Only abstract is available at the moment.
—Ve-Vinn L 15 Oct 2021